[Progress in Tripterygium wilfordiiand its bioactive components in the field of pharmacodynamics and pharmacology]
- PMID: 20450057
- DOI: 10.4268/cjcmm20100425
[Progress in Tripterygium wilfordiiand its bioactive components in the field of pharmacodynamics and pharmacology]
Abstract
In the trials of multi-glycoside of Tripterygium wilfordii (GTW) in the field of pharmacodynamics, some clinical characteristics and symptoms, such as proteinuria, hematuria,joint pain, and skin damage, could be improved in the patients with various diseases including proliferative glomerulonephritis, lupus nephritis, rheumatoid arthritis, psoriasis and other immune-related diseases. In this review, it has been also reported to discuss the effects of GTW and Triptolide (T4), which is a bioactive component in GTW on anti-inflammatory, immunosuppression, and protection of epithelial cell in kidney. On the other hand, it is possible to have some beneficial effects on organ transplant rejection, tumor growth and anti-fertility.
Similar articles
-
Triptolide: progress on research in pharmacodynamics and toxicology.J Ethnopharmacol. 2014 Aug 8;155(1):67-79. doi: 10.1016/j.jep.2014.06.006. Epub 2014 Jun 13. J Ethnopharmacol. 2014. PMID: 24933225 Review.
-
[Preventive effect of multi-glycoside of tripterygium Wilfordii Hook. f. on proteinuria and mesangial injury in experimental mesangial proliferative glomerulonephritis].Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Sep;25(9):817-21. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005. PMID: 16248246 Chinese.
-
[Advanced progress of main pharmacology activities of triptolide].Zhongguo Zhong Yao Za Zhi. 2017 Jul;42(14):2655-2658. doi: 10.19540/j.cnki.cjcmm.20170609.011. Zhongguo Zhong Yao Za Zhi. 2017. PMID: 29098818 Review. Chinese.
-
Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.J Ethnopharmacol. 2014 Feb 12;151(3):1079-1089. doi: 10.1016/j.jep.2013.12.005. Epub 2013 Dec 19. J Ethnopharmacol. 2014. PMID: 24362077
-
Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f.Drugs R D. 2003;4(1):1-18. doi: 10.2165/00126839-200304010-00001. Drugs R D. 2003. PMID: 12568630 Review.
Cited by
-
Triptolide inhibits proliferation, differentiation and induces apoptosis of osteoblastic MC3T3‑E1 cells.Mol Med Rep. 2017 Nov;16(5):7391-7397. doi: 10.3892/mmr.2017.7568. Epub 2017 Sep 21. Mol Med Rep. 2017. PMID: 28944904 Free PMC article.
-
Case report: A rare case of death due to end-stage renal disease caused by Tripterygium wilfordii-induced myelosuppression.Front Med (Lausanne). 2022 Nov 30;9:1036422. doi: 10.3389/fmed.2022.1036422. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36530889 Free PMC article.
-
Protective Effect and Possible Mechanisms of Tripterygium Glycosides in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-Analysis.Oxid Med Cell Longev. 2022 Mar 3;2022:9374895. doi: 10.1155/2022/9374895. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35281463 Free PMC article.
-
Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma.Drug Des Devel Ther. 2015 Nov 16;9:6095-107. doi: 10.2147/DDDT.S92022. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26604697 Free PMC article.
-
Application of nanotechnology in the treatment of glomerulonephritis: current status and future perspectives.J Nanobiotechnology. 2024 Jan 3;22(1):9. doi: 10.1186/s12951-023-02257-8. J Nanobiotechnology. 2024. PMID: 38169389 Free PMC article. Review.